NIFTY 50▲22,147.00
151.15 (0.69%)
SENSEX▲73,088.33
599.34 (0.83%)
NIFTY BANK▲47,574.15
504.70 (1.07%)
TATA MOTORS▼963.20
-8.15 (-0.84%)
INDIAN RAILWAY FINANCE CORP▼141.00
-0.95 (-0.67%)
SUZLON ENERGY▼39.35
-1.80 (-4.37%)
TATA POWER▼428.10
-1.65 (-0.38%)
TATA STEEL▲162.10
2.05 (1.28%)
YES BANK▲23.95
0.05 (0.21%)
INDIAN RENEWABLE ENERGY▼160.70
-2.45 (-1.50%)
RELIANCE INDUSTRIES▲2,940.25
11.60 (0.40%)
RELIANCE POWER▼28.05
-0.65 (-2.26%)
HDFC BANK▲1,531.30
36.60 (2.45%)
RAIL VIKAS NIGAM▼258.45
-1.45 (-0.56%)
VODAFONE IDEA▼12.90
-0.30 (-2.27%)
ADANI POWER▼594.55
-3.55 (-0.59%)
JIO FIN SERVICES LTD▼370.10
-8.30 (-2.19%)
ZOMATO▲189.20
4.00 (2.16%)
NHPC▼87.15
-2.35 (-2.63%)
INDIAN RAILWAY TOURISM CORP▼992.00
-0.95 (-0.10%)
STATE BANK OF INDIA▲750.45
5.65 (0.76%)
INDIAN OIL CORP▼166.65
-2.35 (-1.39%)
MRF▼1,29,157.65
-73.85 (-0.06%)
ITC▲424.75
5.90 (1.41%)
ADANI GREEN ENERGY▼1,770.05
-5.40 (-0.30%)
ADANI ENTERPRISES▲3,026.95
7.65 (0.25%)
JAIPRAKASH POWER VENTURES▼17.05
-0.15 (-0.87%)
ADANI PORT & SEZ▲1,310.00
14.45 (1.12%)
  1. home
    apple-store
  2. stocks
    apple-store
  3. BETA DRUGS LIMITED
stock logo

BETA DRUGS LIMITED Share Price

BETA

₹1,400.00+₹20.05 (1.45%) Past YearLast updated on 19 Apr, 2024 | 03:28 PM IST
₹1,379.95₹1,406.00
L
Show Current Price
H

  • News

  • Company overview

  • Fundamentals

  • Events

  • More

What’s in news?

arrow
Empty state

No data available at the moment

Company overview

About

arrow

Market cap

Market Cap Switch₹1,327 Cr

Open

₹1,379.95

Close

₹1,379.95

Circuit range

₹1,655.90 - ₹1,104.00

Day range

₹1,379.95 - ₹1,406.00

Year range

₹660.00 - ₹1,595.00

Volume

6,400

Avg. traded

₹1,392.08

Revenue (12m)

₹256 Cr

BETA DRUGS LIMITEDBeta Drugs Limited is an India-based company, which is engaged in manufacturing of the wide range of anti-cancer drugs in India. The Company operates through manufacturing of Oncology medicines segment. The Company offers a portfolio consisting of approximately 50 products catering to various oncology diseases, including breast, lung, head, and neck, colorectal, ovarian, gastric, brain, testicular renal, prostate, leukemia, lymphoma, myeloma, supportive. The Company’s oncology portfolio includes various brands, such as AB-PACLI, ADBIRON, ADCARB, ADCIST, Adlante, ADLEAP, ADMIDE, ADOXI, CAPAD, ARBAZ, FISTENT, BUSFAN, Triodelta and others. The Company's subsidiaries include Adley Lab Limited, Adley Formulations Private Limited.

Read more

BETA DRUGS LIMITED Key indicators

arrow

52 week high

₹1,595.00

52 week low

₹660.00

P/E ratio

38.17

P/B ratio

10.8

ROE

21.66%

ROCE

27.93%

Dividend yield

--

Debt/Equity ratio

0.06

EPS

19.57

Learn more

Investment checklist: (3/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Fundamentals

Financial ratios

arrow

  • Profitability

  • Operational

  • Valuation

Operating profit margin

20.42%

Net profit margin

11.92%

ROE

21.66%

ROA

14.97%

ROCE

27.93%

Learn more

BETA DRUGS LIMITED Shareholder returns

arrow

1 day

--

1 week

--

1 month

--

3 months

--

1 year

--

3 years

--

5 years

--

Revenue statement

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Cash flow

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Balance sheet

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

BETA DRUGS LIMITED Share Price history

arrow
DayOpenCloseDay’s change
Thu, Apr 18 2024
₹1,354.85
₹1,379.95
+1.82%
Tue, Apr 16 2024
₹1,266.25
₹1,354.85
+6.54%
Mon, Apr 15 2024
₹1,281.05
₹1,297.00
+1.23%
Fri, Apr 12 2024
₹1,320.00
₹1,302.00
-1.38%
Wed, Apr 10 2024
₹1,315.00
₹1,304.65
-0.79%
Tue, Apr 9 2024
₹1,331.10
₹1,315.75
-1.17%
Mon, Apr 8 2024
₹1,352.40
₹1,331.10
-1.60%
Fri, Apr 5 2024
₹1,390.00
₹1,380.00
-0.72%

Shareholding info

arrow

Promoters (66.73%)

Mutual Funds (0%)

Retail and other (32.91%)

Foreign institutions-FII (0.32%)

Other domestic institutions (0.04%)

Promoters

Learn more

Events

Empty state

No data available at the moment

Frequently asked questions